Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis
HDAC 和 PDE5 的双重药理靶向作用可抑制胆道炎症和纤维化小鼠模型中的肝病进展
期刊:Cancers
影响因子:
doi:10.3390/cancers12123748
Alex Claveria-Cabello, Leticia Colyn, Iker Uriarte, Maria Ujue Latasa, Maria Arechederra, Jose M Herranz, Laura Alvarez, Jesus M Urman, Maria L Martinez-Chantar, Jesus M Banales, Bruno Sangro, Krista Rombouts, Julen Oyarzabal, Jose J G Marin, Carmen Berasain, Matias A Avila, Maite G Fernandez-Barren